Bilateral laparoscopic adrenalectomy for congenital adrenal hyperplasia with severe hypertension, resulting from two novel mutations in splice donor sites of CYP11B1
- PMID: 11095433
- DOI: 10.1210/jcem.85.11.6897
Bilateral laparoscopic adrenalectomy for congenital adrenal hyperplasia with severe hypertension, resulting from two novel mutations in splice donor sites of CYP11B1
Abstract
We present an in vivo and in vitro study of congenital adrenal hyperplasia in a patient with 11beta-hydroxylase deficiency. Sequencing of the CYP11B1 gene showed two new base substitutions, a conservative 954 G-->C transversion at the last base of exon 5 (T318T), and a IVS8 + 4A-->G transition in intron 8. In addition, two polymorphisms were found in exons 1 and 2. The genetically female patient was raised as a male because of severe pseudohermaphroditism. Glucocorticoid-suppressive treatment encountered difficulties in equilibration and compliance, resulting in uncontrolled hypertension with pronounced hypertrophic cardiomyopathy. At 42 yr of age the occurrence of central retinal vein occlusion with permanent loss of left eye vision led to the decision to perform bilateral laparoscopic adrenalectomy. Surgery was followed by normalization of blood pressure and good compliance with glucocorticoid and androgen substitutive therapies. In vitro, adrenal cells in culture and isolated mitochondria showed extremely low 11beta-hydroxylase activity. Analysis of adrenal CYP11B1 messenger ribonucleic acid (mRNA) by RT-PCR and sequencing showed the expression of a shorter mRNA that lacked exon 8 and did not contain either the exon 5 mutation or the exon 1 and 2 polymorphisms. This suggested that one CYP11B1 allele carried the intron 8 mutation, responsible for skipping exon 8. The other allele carried the exon 5 mutation, and its mRNA was not detectable. Western blot analysis showed weak expression of a shorter CYP11B immunoreactive band of 43 kDa, consistent with truncation of exon 8. Thus, bilateral adrenalectomy in this patient allowed effective treatment of severe hypertension and helped in understanding the mechanisms and physiopathological consequences of two novel mutations of CYP11B1.
Similar articles
-
Two novel mutations in splice donor sites of CYP11B1 in congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency.Endocr Res. 2000 Nov;26(4):797-801. doi: 10.3109/07435800009048602. Endocr Res. 2000. PMID: 11196457
-
Bilateral adrenalectomy for severe hypertension in congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency: long term follow-up.Ann Endocrinol (Paris). 2009 Apr;70(2):113-8. doi: 10.1016/j.ando.2008.12.005. Epub 2009 Feb 4. Ann Endocrinol (Paris). 2009. PMID: 19195642
-
Phenotypic, metabolic, and molecular genetic characterization of six patients with congenital adrenal hyperplasia caused by novel mutations in the CYP11B1 gene.J Steroid Biochem Mol Biol. 2016 Jan;155(Pt A):126-34. doi: 10.1016/j.jsbmb.2015.10.011. Epub 2015 Oct 22. J Steroid Biochem Mol Biol. 2016. PMID: 26476331
-
Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia.Trends Endocrinol Metab. 2008 Apr;19(3):96-9. doi: 10.1016/j.tem.2008.01.002. Epub 2008 Feb 21. Trends Endocrinol Metab. 2008. PMID: 18294861 Review.
-
Steroid 11 beta-hydroxylase deficiency and related disorders.Endocrinol Metab Clin North Am. 1994 Jun;23(2):325-39. Endocrinol Metab Clin North Am. 1994. PMID: 8070425 Review.
Cited by
-
Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia.Front Endocrinol (Lausanne). 2022 Aug 1;13:934675. doi: 10.3389/fendo.2022.934675. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35979433 Free PMC article. Review.
-
Clinical and molecular characterization of 10 Chinese children with congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency.World J Pediatr. 2024 Apr;20(4):422-433. doi: 10.1007/s12519-023-00739-1. Epub 2023 Jul 24. World J Pediatr. 2024. PMID: 37486441 Free PMC article.
-
Progress in molecular-genetic studies on congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency.World J Pediatr. 2008 May;4(2):85-90. doi: 10.1007/s12519-008-0016-8. World J Pediatr. 2008. PMID: 18661760 Review.
-
Steroid 11-beta hydroxylase deficiency caused by compound heterozygosity for a novel mutation in intron 7 (IVS 7 DS+4A to G) in one CYP11B1 allele and R448H in exon 8 in the other.Eur J Pediatr. 2010 Jul;169(7):891-4. doi: 10.1007/s00431-009-1110-1. Epub 2009 Dec 22. Eur J Pediatr. 2010. PMID: 20024693
-
A Chinese patient with 11β-hydroxylase deficiency due to novel compound heterozygous mutation in CYP11B1 gene: a case report.BMC Endocr Disord. 2018 Sep 21;18(1):68. doi: 10.1186/s12902-018-0295-6. BMC Endocr Disord. 2018. PMID: 30241518 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical